BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36993465)

  • 21. Widespread arenavirus occurrence and seroprevalence in small mammals, Nigeria.
    Olayemi A; Oyeyiola A; Obadare A; Igbokwe J; Adesina AS; Onwe F; Ukwaja KN; Ajayi NA; Rieger T; Günther S; Fichet-Calvet E
    Parasit Vectors; 2018 Jul; 11(1):416. PubMed ID: 30005641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone.
    Koch MR; Kanneh L; Wise PH; Kurina LM; Alhasan F; Garry RF; Schieffelin JS; Shaffer JG; Grant DS
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009576. PubMed ID: 34260615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic basis underlying Lassa fever endemics in the Mano River region, West Africa.
    Li Y
    Virology; 2023 Feb; 579():128-136. PubMed ID: 36669329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine platforms to control Lassa fever.
    Lukashevich IS; Pushko P
    Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC-I alleles mediate clearance and antibody response to the zoonotic Lassa virus in Mastomys rodent reservoirs.
    Olayemi A; Schmid DW; Fleischer R; Wilhelm K; Heni AC; Mueller-Klein N; Haikukutu L; Fichet-Calvet E; Günther S; Sommer S
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011984. PubMed ID: 38421939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings.
    Mazzola LT; Kelly-Cirino C
    BMJ Glob Health; 2019; 4(Suppl 2):e001116. PubMed ID: 30899575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining Ancestry between Rodent- and Human-Derived Virus Sequences in Endemic Foci: Towards a More Integral Molecular Epidemiology of Lassa Fever within West Africa.
    Olayemi A; Adesina AS; Strecker T; Magassouba N; Fichet-Calvet E
    Biology (Basel); 2020 Feb; 9(2):. PubMed ID: 32046182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria.
    Happi AN; Ogunsanya OA; Ayinla AO; Sijuwola AE; Saibu FM; Akano K; Nwofoke C; Elias OT; Achonduh-Atijegbe O; Daodu RO; Adedokun OA; Adeyemo A; Ogundana KE; Lawal OZ; Parker E; Nosamiefan I; Okolie J; Parker ZF; McCauley MD; Eller LA; Lombardi K; Tiamiyu AB; Iroezindu M; Akinwale E; Njatou TLFA; Mebrahtu T; Broach E; Zuppe A; Prins P; Lay J; Amare M; Modjarrad K; Collins ND; Vasan S; Tucker C; Daye S; Happi CT
    Emerg Microbes Infect; 2024 Dec; 13(1):2294859. PubMed ID: 38088796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.
    Sogoba N; Rosenke K; Adjemian J; Diawara SI; Maiga O; Keita M; Konaté D; Keita AS; Sissoko I; Boisen M; Nelson D; Oottamasathien D; Millett M; Garry RF; Branco LM; Traoré SF; Doumbia S; Feldmann H; Safronetz D
    Emerg Infect Dis; 2016 Apr; 22(4):657-63. PubMed ID: 26981786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatio-temporal spread of Lassa virus and a new rodent host in the Mano River Union area, West Africa.
    Bangura U; Davis C; Lamin J; Bangura J; Soropogui B; Davison AJ; Nichols J; Vucak M; Dawson M; Ansumana R; Sondufu D; Cadar D; Rieger T; Thomson E; Sahr F; Magassouba N; Ghersi B; Bird BH; Fichet-Calvet E
    Emerg Microbes Infect; 2024 Dec; 13(1):2290834. PubMed ID: 38047354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. At Home with
    Bonwitt J; Sáez AM; Lamin J; Ansumana R; Dawson M; Buanie J; Lamin J; Sondufu D; Borchert M; Sahr F; Fichet-Calvet E; Brown H
    Am J Trop Med Hyg; 2017 Apr; 96(4):935-943. PubMed ID: 28167603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lassa fever - the road ahead.
    Garry RF
    Nat Rev Microbiol; 2023 Feb; 21(2):87-96. PubMed ID: 36097163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak.
    Boisen ML; Uyigue E; Aiyepada J; Siddle KJ; Oestereich L; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Eromon P; Kayode AT; Odia I; Adomeh DI; Muoebonam EB; Akhilomen P; Okonofua G; Osiemi B; Omoregie O; Airende M; Agbukor J; Ehikhametalor S; Aire CO; Duraffour S; Pahlmann M; Böhm W; Barnes KG; Mehta S; Momoh M; Sandi JD; Goba A; Folarin OA; Ogbaini-Emovan E; Asogun DA; Tobin EA; Akpede GO; Okogbenin SA; Okokhere PO; Grant DS; Schieffelin JS; Sabeti PC; Günther S; Happi CT; Branco LM; Garry RF
    Sci Rep; 2020 May; 10(1):8724. PubMed ID: 32457420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.
    Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H
    PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
    Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
    EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea.
    Mariën J; Lo Iacono G; Rieger T; Magassouba N; Günther S; Fichet-Calvet E
    Emerg Microbes Infect; 2020 Dec; 9(1):1055-1064. PubMed ID: 32459576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lassa Fever Natural History and Clinical Management.
    Grant DS; Samuels RJ; Garry RF; Schieffelin JS
    Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.